{"id":3218,"date":"2026-04-10T08:29:11","date_gmt":"2026-04-10T05:29:11","guid":{"rendered":"https:\/\/merkezlaboratuvari.com\/test-listesi\/rubella-kizamikcik-igm-vidas-2\/"},"modified":"2026-04-21T12:38:34","modified_gmt":"2026-04-21T09:38:34","slug":"rubella-kizamikcik-igm-vidas","status":"publish","type":"page","link":"https:\/\/merkezlaboratuvari.com\/ar\/test-listesi\/rubella-kizamikcik-igm-vidas\/","title":{"rendered":"Rubella (K\u0131zam\u0131k\u00e7\u0131k) IgM (Vidas)"},"content":{"rendered":"<h1>Rubella (K\u0131zam\u0131k\u00e7\u0131k) IgM (Vidas)<\/h1>\n<h2>Laboratuvar Bilgileri<\/h2>\n<ul>\n<li><strong>Yeni Kod:<\/strong> BIO4004<\/li>\n<li><strong>SUT Kodu:<\/strong> 906840.0<\/li>\n<li><strong>Eski Kod:<\/strong> HR1201<\/li>\n<li><strong>Kategori:<\/strong> \u0643\u064a\u0645\u064a\u0627\u0621 \u062d\u064a\u0648\u064a\u0629<\/li>\n<li><strong>Numune T\u00fcr\u00fc:<\/strong> Serum<\/li>\n<li><strong>Numune Kab\u0131:<\/strong> Sar\u0131 Kapak<\/li>\n<li><strong>\u00c7al\u0131\u015fma G\u00fcn\u00fc:<\/strong> Her g\u00fcn<\/li>\n<li><strong>\u00d6nemli Kriter:<\/strong> \u00c7al\u0131\u015fma g\u00fcn\u00fcnde laboratuvar\u0131m\u0131zda kabul edilen testler, bir sonraki \u00e7al\u0131\u015fma program\u0131nda i\u015fleme al\u0131nacakt\u0131r.<\/li>\n<li><strong>Raporlama Tarihi:<\/strong> Ertesi g\u00fcn 18:00<\/li>\n<\/ul>\n<h2>Rubella (K\u0131zam\u0131k\u00e7\u0131k) IgM (Vidas) Testi Nedir?<\/h2>\n<p>Rubella (K\u0131zam\u0131k\u00e7\u0131k) IgM (Vidas), laboratuvar ortam\u0131nda de\u011ferlendirilen bir biyokimya testidir. De\u011ferlendirme \u00e7o\u011fu zaman serum \u00f6rne\u011fi \u00fczerinden planlan\u0131r.<\/p>\n<p>Rubella IgM, Rubella vir\u00fcs\u00fcne (k\u0131zam\u0131k\u00e7\u0131k) kar\u015f\u0131 olu\u015fan IgM s\u0131n\u0131f\u0131 antikorlar\u0131 tespit eden serolojik bir testtir. Akut Rubella enfeksiyonunun tan\u0131s\u0131nda kullan\u0131l\u0131r. IgM antikorlar\u0131 enfeksiyonun ba\u015flang\u0131c\u0131ndan birka\u00e7 g\u00fcn sonra y\u00fckselir ve genellikle 6\u20138 hafta i\u00e7inde kaybolur.<\/p>\n<p>Bu testin klinik anlam\u0131; istem nedeni, hastan\u0131n yak\u0131nmalar\u0131, ya\u015f\u0131, e\u015flik eden hastal\u0131klar\u0131, kullan\u0131lan y\u00f6ntem ve di\u011fer laboratuvar bulgular\u0131 ile birlikte de\u011ferlendirilir. Bu nedenle sonu\u00e7, tek ba\u015f\u0131na de\u011fil, b\u00fct\u00fcnc\u00fcl t\u0131bbi \u00e7er\u00e7eve i\u00e7inde yorumlanmal\u0131d\u0131r.<\/p>\n<h2>Rubella (K\u0131zam\u0131k\u00e7\u0131k) IgM (Vidas) Hangi Durumlarda \u0130stenir?<\/h2>\n<p>Rubella (K\u0131zam\u0131k\u00e7\u0131k) IgM (Vidas) testi, hekim taraf\u0131ndan klinik gereklilik g\u00f6r\u00fclen durumlarda istenebilir. \u0130stem gerek\u00e7esi hastan\u0131n mevcut tablosuna g\u00f6re de\u011fi\u015febilir.<\/p>\n<ul>\n<li>Gebelikte akut Rubella enfeksiyonu \u015f\u00fcphesinde<\/li>\n<li>K\u0131zam\u0131k\u00e7\u0131k benzeri d\u00f6k\u00fcnt\u00fcl\u00fc hastal\u0131klarda ay\u0131r\u0131c\u0131 tan\u0131<\/li>\n<li>Konjenital rubella sendromu ara\u015ft\u0131rmas\u0131 (yenido\u011fanda)<\/li>\n<li>Rubella salg\u0131nlar\u0131nda olgu tespiti<\/li>\n<\/ul>\n<p>Ayn\u0131 test farkl\u0131 hastalarda farkl\u0131 klinik sorulara yan\u0131t aramak amac\u0131yla kullan\u0131labildi\u011fi i\u00e7in, nihai de\u011ferlendirme her zaman ki\u015fisel t\u0131bbi \u00f6yk\u00fc ve muayene bulgular\u0131 ile birlikte yap\u0131lmal\u0131d\u0131r.<\/p>\n<h2>Rubella (K\u0131zam\u0131k\u00e7\u0131k) IgM (Vidas) Testi \u00d6ncesi Haz\u0131rl\u0131k<\/h2>\n<p>Haz\u0131rl\u0131k gereksinimi; testin t\u00fcr\u00fcne, numune yap\u0131s\u0131na ve laboratuvar\u0131n \u00e7al\u0131\u015fma kurallar\u0131na g\u00f6re de\u011fi\u015febilir. Test \u00f6ncesinde laboratuvar\u0131n ve hekimin verdi\u011fi talimatlar esas al\u0131nmal\u0131d\u0131r.<\/p>\n<ul>\n<li>\u00d6zel bir haz\u0131rl\u0131k gerekmez.<\/li>\n<li>A\u00e7l\u0131k \u015fart\u0131 yoktur.<\/li>\n<\/ul>\n<p>Kullan\u0131lan ila\u00e7lar, takviyeler, yak\u0131n d\u00f6nemde ge\u00e7irilen hastal\u0131klar ve e\u015flik eden kronik durumlar sonucun yorumlanmas\u0131n\u0131 etkileyebilece\u011fi i\u00e7in sa\u011fl\u0131k profesyoneli ile payla\u015f\u0131lmal\u0131d\u0131r.<\/p>\n<h2>Rubella (K\u0131zam\u0131k\u00e7\u0131k) IgM (Vidas) Testi Nas\u0131l Yap\u0131l\u0131r?<\/h2>\n<p>Rubella (K\u0131zam\u0131k\u00e7\u0131k) IgM (Vidas) testi, uygun biyolojik \u00f6rnek al\u0131nd\u0131ktan sonra laboratuvar\u0131n belirledi\u011fi y\u00f6ntemle \u00e7al\u0131\u015f\u0131l\u0131r. Numunenin do\u011fru zamanda, uygun kapta ve uygun ta\u015f\u0131ma ko\u015fullar\u0131nda ula\u015ft\u0131r\u0131lmas\u0131 test kalitesi a\u00e7\u0131s\u0131ndan \u00f6nem ta\u015f\u0131r.<\/p>\n<ul>\n<li><strong>Numune T\u00fcr\u00fc:<\/strong> Serum<\/li>\n<li><strong>Numune Kab\u0131:<\/strong> Sar\u0131 Kapak<\/li>\n<li><strong>\u00c7al\u0131\u015fma G\u00fcn\u00fc:<\/strong> Her g\u00fcn<\/li>\n<li><strong>\u00d6nemli Kriter:<\/strong> \u00c7al\u0131\u015fma g\u00fcn\u00fcnde laboratuvar\u0131m\u0131zda kabul edilen testler, bir sonraki \u00e7al\u0131\u015fma program\u0131nda i\u015fleme al\u0131nacakt\u0131r.<\/li>\n<li><strong>Raporlama Tarihi:<\/strong> Ertesi g\u00fcn 18:00<\/li>\n<\/ul>\n<ul>\n<li>Koldan ven\u00f6z kan \u00f6rne\u011fi al\u0131n\u0131r (serum t\u00fcp\u00fc).<\/li>\n<li>Sonu\u00e7 genellikle 1\u20132 i\u015f g\u00fcn\u00fc i\u00e7inde \u00e7\u0131kar.<\/li>\n<li>ELISA veya kemil\u00fcminesans y\u00f6ntemle \u00e7al\u0131\u015f\u0131l\u0131r.<\/li>\n<\/ul>\n<p>Baz\u0131 durumlarda \u00f6rnek kalitesi, numune miktar\u0131, ta\u015f\u0131ma s\u00fcresi veya teknik tekrar gereksinimi raporlama s\u00fcresini ve sonucun g\u00fcvenilirli\u011fini etkileyebilir.<\/p>\n<h2>Rubella (K\u0131zam\u0131k\u00e7\u0131k) IgM (Vidas) Testi Ka\u00e7 G\u00fcnde \u00c7\u0131kar?<\/h2>\n<p>Mevcut laboratuvar bilgisine g\u00f6re bu test i\u00e7in raporlama s\u00fcresi: <strong>Ertesi g\u00fcn 18:00<\/strong> \u015feklindedir.<\/p>\n<p>Numunenin kabul zaman\u0131, laboratuvar\u0131n \u00e7al\u0131\u015fma plan\u0131, resmi tatiller veya gerekti\u011finde tekrar \u00e7al\u0131\u015fma gibi etkenler sonucu etkileyebilece\u011fi i\u00e7in en g\u00fcncel bilgi rapor tarihi \u00fczerinden de\u011ferlendirilmelidir.<\/p>\n<h2>Referans De\u011ferleri ve Sonu\u00e7lar\u0131n De\u011ferlendirilmesi<\/h2>\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><thead><tr><th>\u0627\u0644\u0646\u062a\u064a\u062c\u0629<\/th><th>Yorum<\/th><\/tr><\/thead><tbody><tr><td>Negatif<\/td><td>Akut Rubella enfeksiyonu d\u00fc\u015f\u00fcn\u00fclmez<\/td><\/tr><tr><td>Pozitif<\/td><td>Akut veya yak\u0131n ge\u00e7mi\u015fte Rubella enfeksiyonu<\/td><\/tr><\/tbody><\/table><\/figure>\n\n<p>Referans bilgileri; kullan\u0131lan y\u00f6ntem, ya\u015f grubu, biyolojik \u00f6rnek tipi ve laboratuvar standard\u0131na g\u00f6re de\u011fi\u015febilece\u011finden, rapor \u00fczerinde yer alan laboratuvar yorumu esas al\u0131nmal\u0131d\u0131r.<\/p>\n<h2>Rubella (K\u0131zam\u0131k\u00e7\u0131k) IgM (Vidas) Sonucu Nas\u0131l Yorumlan\u0131r?<\/h2>\n<p>Test sonucu tek ba\u015f\u0131na kesin tan\u0131 koydurmaz. Sonu\u00e7; klinik bulgular, di\u011fer laboratuvar verileri ve gerekli g\u00f6r\u00fcld\u00fc\u011f\u00fcnde ek incelemeler ile birlikte de\u011ferlendirilir.<\/p>\n<ul>\n<li><strong>Pozitif sonu\u00e7<\/strong>: Akut veya yak\u0131n zamanda ge\u00e7irilmi\u015f Rubella enfeksiyonunu d\u00fc\u015f\u00fcnd\u00fcr\u00fcr. Gebeli\u011fin ilk trimesterinde primer Rubella enfeksiyonu konjenital rubella sendromu riskini belirgin art\u0131r\u0131r (katarakt, sa\u011f\u0131rl\u0131k, kalp defektleri).<\/li>\n<li><strong>Negatif sonu\u00e7<\/strong>: Akut Rubella enfeksiyonu d\u00fc\u015f\u00fcn\u00fclmez. \u00c7ok erken d\u00f6nemde negatif olabilir; klinik \u015f\u00fcphe varsa 1\u20132 hafta sonra tekrarlan\u0131r.<\/li>\n<li>Rubella IgM, a\u015f\u0131lamadan sonra da ge\u00e7ici olarak pozitifle\u015febilir; bu durum a\u015f\u0131 \u00f6yk\u00fcs\u00fc sorgulanarak ay\u0131rt edilmelidir.<\/li>\n<li>Yanl\u0131\u015f pozitiflik (EBV enfeksiyonu, romatoid fakt\u00f6r pozitifli\u011fi) olas\u0131l\u0131\u011f\u0131 g\u00f6z \u00f6n\u00fcnde bulundurulmal\u0131d\u0131r.<\/li>\n<\/ul>\n<p>\u00d6zellikle s\u0131n\u0131rda, d\u00fc\u015f\u00fck d\u00fczeyli veya beklenmeyen sonu\u00e7larda klinik korelasyon gerekir. Gerekti\u011finde tekrar test, panel de\u011ferlendirmesi veya ek laboratuvar incelemeleri planlanabilir.<\/p>\n<h2>Testin S\u0131n\u0131rl\u0131l\u0131klar\u0131<\/h2>\n<p>Her laboratuvar testinde oldu\u011fu gibi bu incelemenin de baz\u0131 s\u0131n\u0131rl\u0131l\u0131klar\u0131 vard\u0131r. Sonu\u00e7; \u00f6rnek kalitesi, \u00f6rnekleme zaman\u0131, ta\u015f\u0131ma ko\u015fullar\u0131 ve klinik ba\u011flamdan etkilenebilir.<\/p>\n<ul>\n<li>Tek bir laboratuvar sonucu, klinik \u00e7er\u00e7eve d\u0131\u015f\u0131nda eksik yorumlanabilir.<\/li>\n<li>Uygun olmayan numune kalitesi sonucun g\u00fcvenilirli\u011fini azaltabilir.<\/li>\n<li>Gerekti\u011finde ek testler olmadan tek ba\u015f\u0131na karar vermek yan\u0131lt\u0131c\u0131 olabilir.<\/li>\n<\/ul>\n<h2>Olas\u0131 Riskler<\/h2>\n<p>Risk \u00e7o\u011funlukla numune alma ve numune y\u00f6netimi s\u00fcreci ile ili\u015fkilidir. Testin kendisinden \u00e7ok, \u00f6rne\u011fin al\u0131nmas\u0131 ve uygun ko\u015fullarda \u00e7al\u0131\u015f\u0131lmas\u0131 \u00f6nem ta\u015f\u0131r.<\/p>\n<ul>\n<li>Kan al\u0131m\u0131na ba\u011fl\u0131 hafif a\u011fr\u0131, morarma veya nadiren enfeksiyon riski vard\u0131r.<\/li>\n<li>Testin kendisine \u00f6zg\u00fc ciddi bir risk bulunmaz.<\/li>\n<\/ul>","protected":false},"excerpt":{"rendered":"<p>Rubella (K\u0131zam\u0131k\u00e7\u0131k) IgM (Vidas) Laboratuvar Bilgileri Yeni Kod: BIO4004 SUT Kodu: 906840.0 Eski Kod: HR1201 Kategori: Biyokimya Numune T\u00fcr\u00fc: Serum Numune Kab\u0131: Sar\u0131 Kapak \u00c7al\u0131\u015fma G\u00fcn\u00fc: Her g\u00fcn \u00d6nemli Kriter: \u00c7al\u0131\u015fma g\u00fcn\u00fcnde laboratuvar\u0131m\u0131zda kabul edilen testler, bir sonraki \u00e7al\u0131\u015fma program\u0131nda i\u015fleme al\u0131nacakt\u0131r. Raporlama Tarihi: Ertesi g\u00fcn 18:00 Rubella (K\u0131zam\u0131k\u00e7\u0131k) IgM (Vidas) Testi Nedir? Rubella (K\u0131zam\u0131k\u00e7\u0131k) [&hellip;]<\/p>\n","protected":false},"author":0,"featured_media":0,"parent":5,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"test_category":"Biyokimya","test_kodu":"BIO4004","numune_turu":"Serum","numune_kabi":"Sar\u0131 Kapak","calisma_gunu":"Her g\u00fcn","onemli_kriter":"\u00c7al\u0131\u015fma g\u00fcn\u00fcnde laboratuvar\u0131m\u0131zda kabul edilen testler, bir sonraki \u00e7al\u0131\u015fma program\u0131nda i\u015fleme al\u0131nacakt\u0131r.","raporlama_tarihi":"Ertesi g\u00fcn 18:00","numune_red_kriterleri":"","aktarim_kodu":"","loinc_kodu":"","sut_kodu":"906840","akredite":"","numune_miktari":"","alternatif_ornek":"","numune_alinma_sekli":"","stabilite_ozellikleri":"","calisma_yontemi":"","test_bilgisi":"","footnotes":""},"class_list":["post-3218","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/merkezlaboratuvari.com\/ar\/wp-json\/wp\/v2\/pages\/3218","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/merkezlaboratuvari.com\/ar\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/merkezlaboratuvari.com\/ar\/wp-json\/wp\/v2\/types\/page"}],"replies":[{"embeddable":true,"href":"https:\/\/merkezlaboratuvari.com\/ar\/wp-json\/wp\/v2\/comments?post=3218"}],"version-history":[{"count":4,"href":"https:\/\/merkezlaboratuvari.com\/ar\/wp-json\/wp\/v2\/pages\/3218\/revisions"}],"predecessor-version":[{"id":8904,"href":"https:\/\/merkezlaboratuvari.com\/ar\/wp-json\/wp\/v2\/pages\/3218\/revisions\/8904"}],"up":[{"embeddable":true,"href":"https:\/\/merkezlaboratuvari.com\/ar\/wp-json\/wp\/v2\/pages\/5"}],"wp:attachment":[{"href":"https:\/\/merkezlaboratuvari.com\/ar\/wp-json\/wp\/v2\/media?parent=3218"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}